Skip to content
Search

Latest Stories

Community pharmacists urge PM to intervene and waive off £300m cash advance, 'The Times' reports

Over a thousand community pharmacists have written to the prime minister asking him to intervene as the sector faces financial ruin in the wake of Covid-19, a national daily has reported.

In a letter to Boris Johnson, they explained how NHS payments, including the cash injection of £300 million as advanced payment, do not make up for the shortfall of what pharmacies have already spent during the coronavirus crisis.


“While we welcome recent comments from the government recognising the role that pharmacies are playing, we need to see these supportive words backed up with further concrete action,” they wrote, highlighting how the sector stayed open whilst continuing to see patients and supply vital medicines since the start of the pandemic.

“We are putting ourselves at risk every day to help keep Britain healthy,” the letter from members of the National Pharmacy Association (NPA) added.

The Times pointed out in a report today (May 26) that small community pharmacies “have been operating at loss over the past three months,” because of higher drug bills, overtime payments and costs for personal protective equipment that is free to other parts of the NHS. Community pharmacists have long complained that the PPE kits provided by Public Health England have been inadequate.

The paper quoted Mark Lyonette, chief executive of the NPA, as saying that many of the pharmacy body’s members would have been “better off if they’d closed their doors to the public” instead of bearing a “heavy burden” for their role in tackling the crisis.

National pharmacy bodies have told The Times of the huge frustration there were within the sector at ministers paying tribute to community pharmacy in public on one hand, while the Treasury trying to reclaim the £300 million on the other.

The report explained that although pharmacies were allowed to stay open, their retail sales only amounted to about 10 per cent of total revenues, which resulted in many reporting a drop in sales since the start of the pandemic.

“The £300 million was handed over because in the weeks before the lockdown was announced pharmacists were struggling because of customers stockpiling medicines. This led to wholesale price increases of many prescription medicines above the amount they are reimbursed by the NHS,” The Times wrote.

“More recent NHS payments do not make up for the shortfall of what pharmacies have already spent on drugs and, they claim, they are in effect being asked to subsidise the health service,” it added.

More For You

Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
PHOENIX expands operations with new depot in Aberdeen

Representational image

Photo credit: PHOENIX

PHOENIX opens new depot in Aberdeen

PHOENIX has announced the opening of a new depot in Aberdeen to support its growing customer base in Scotland.

The pharmaceutical wholesaler already operates 13 depots across the UK, collectively delivering over 250 million packs of medicines each year.

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less